10 Truths & 10 Fallacies of Psychopharmacology
Separate scientific knowledge from marketing hype in psychiatry with Harvard lecturer Dr. Nassir Ghaemi, MD
These classes took place between September 5-26, 2025. Your enrollment includes access to all session recordings in our Memberkit area, where you can also comment and ask questions beneath each video.
Masterclass 1 — A New Psychopharmacology Nomenclature
- – Classify meds by mechanism, not marketing-era labels or brands.
– Predict benefits, harms, and limits from receptor-level first principles.
– Spot when familiar drug names hide different mechanisms and outcomes.
Masterclass 2 — Fundamentals of Neurobiology for Prescribers
– Focus on decision-changing neurobiology, not forgettable academic trivia.
– Map dopamine, serotonin, norepinephrine circuits to behavior and symptoms.
– Why serotonin alone fails: include GABA–glutamate balance and networks.
Masterclass 3 — Drug Structures & Mechanisms You Can Use
– Link molecular scaffolds to mechanism patterns you can anticipate.
– See when look-alike drugs differ—and choose the right one.
– Cut polypharmacy: design simpler, durable regimens that actually stick.
Join world-renowned psychiatrist Nassir Ghaemi, M.D., for a three-part, 60-minute masterclasses that unpack the first three chapters of the forthcoming 2nd edition of Clinical Psychopharmacology: Principles & Practice.
• Topics: a new psychopharmacology nomenclature, fundamentals of neurobiology, and the core structures & mechanisms of psychotropic drugs.
• Have access to all questions and answers during the sessions.
• Lifetime access: recordings, slide decks and reading guides stay permanently in your private member area.
Perfect for clinicians, students and curious minds seeking an evidence-based, myth-busting introduction to modern psychopharmacology.
About Dr. Nassir Ghaemi
Nassir Ghaemi MD MPH is a psychiatrist and researcher specializing in depression and bipolar illness. He is Professor of Psychiatry at Tufts Medical Center in Boston, Clinical Lecturer at Harvard Medical School, teaches at the Cambridge Health Alliance.
Formerly employed at Novartis Institutes of Biomedical Research in Cambridge MA, where he lead clinical psychiatry research in early drug discovery. He is author of numerous books including the bestselling A First-Rate Madness: Uncovering the Links between Mental Illness and Leadership, and, most recently, Clinical Psychopharmacology,
He runs a clinical education website, The Psychiatry Letter with hundreds of readers over the world. He has published over 300 scientific papers, and serves on the editorial board of numerous journals.
